Substantial grant awarded in the fight against ovarian cancer
Professor Pradeep Tanwar and his team have studied women with a family history of ovarian cancer to identify a blood-based protein biomarker that could help save the lives of millions of ovarian cancer patients around the world.
The group has been awarded $595,000 by the Ovarian Cancer Research Foundation (OCRF) to validate this biomarker in a large cohort of patients so that this novel technology can be brought to the fore in the battle against ovarian cancer.
Ovarian cancer is the most lethal gynaecological cancer, largely due to high rates of late diagnosis.
This work aims to establish methods for detection of early-stage ovarian cancer.
Related news
- NSW research trials report outcomes for women's health: pharmacist-led UTI and oral contraceptive services
- Prominent groundwater scientist appointed to lead research and innovation at University of Newcastle
- Culturally led research to improve Indigenous heart and stroke outcomes
- $1.09 million to drive innovation in green iron, infrastructure safety and robotics
- Hunter Insights Series explores the regional impacts of NDIS reform
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.